NOVARTIS N/ CH0012005267 /
29/07/2024 17:30:53 | Chg. +0.62 | Volume | Bid20:58:24 | Ask20:58:24 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
98.07CHF | +0.64% | 1.97 mill. Turnover: 192.82 mill. |
97.50Bid Size: 150 | -Ask Size: 901 | 222.92 bill.CHF | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 7.15 USD | 124.14% |
EPS Diluted: | - USD | 123.97% |
Revenues per Share: | 20.49 USD | -14.09% |
Book Value per Share: | 20.49 USD | -26.91% |
Cash Flow per Share: | 6.35 USD | 227.31% |
Dividend per Share: | 3.90 USD | 4.00% |
Total | in mill. | |
Revenues: | 46,660.00 USD | -7.69% |
Net Income: | 14,850.00 USD | 113.52% |
Operating Cash Flow: | 14,458.00 USD | - |
Cash and Cash Equivalents: | 13,393.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 15.49 | 14.06 |
P/S Ratio: | 5.41 | 4.91 |
P/BV ratio: | 5.41 | 4.91 |
P/CF Ratio: | 17.45 | 15.84 |
PEG: | 0.12 | 0.11 |
Earnings Yield: | 6.46% | 7.11% |
Dividend Yield: | 3.52% | 3.88% |
Market Capitalization | ||
Market Capitalization: | 222.92 bill. CHF | 192.57 bill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | 2.93 mill. CHF | 2.53 mill. CHF |
Shares Outstanding: | 2.03 bill. |
Profitability
Gross Profit Margin: | 73.27% |
EBIT Margin: | 20.94% |
Net Profit Margin: | 31.83% |
Return on Equity: | 31.82% |
Return on Assets: | 14.86% |
Financial Strength
Liquidity I / Cash Ratio: | 50.75% |
Liquidity II / Quick Ratio: | 77.68% |
Liquidity III / Current Ratio: | 115.50% |
Debt / Equity Ratio: | 114.17% |
Dynam. Debt / Equity Ratio: | 368.50% |
Efficiency
Employees: | 76,057 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 613,487.25 USD |
Net Income / Employee: | 195,248.30 USD |
Total Assets / Employee: | 1,314,080.23 USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | IFRS |
Currency: | USD |